Inhibrx Biosciences (INBX) Tax Provisions (2023 - 2026)

Inhibrx Biosciences (INBX) has reported Tax Provisions for 3 consecutive years, with $2000.0 the latest figure, recorded in Q2 2025.

• In Q2 2025, Tax Provisions changed 0.0% year-over-year to $2000.0; the TTM figure through Dec 2025 stood at $2000.0 (changed 0.0% YoY), while the FY2025 annual figure was $2000.0, changed 0.0% from the prior year.
• Tax Provisions was little changed at $2000.0 in Q2 2025 per INBX's latest filing, from $2000.0 in the prior quarter.
• Across five years, Tax Provisions topped out at $5000.0 in Q2 2023 and bottomed at -$4000.0 in Q4 2023.
• Historically, Tax Provisions has averaged $1400.0 across 3 years, with a median of $2000.0 in 2023.
• Annual changes were most pronounced in 2024 — Tax Provisions plunged 60.0% — and 2025, when it changed 0.0%.
• Inhibrx Biosciences' Tax Provisions stood at -$4000.0 in 2023, then soared by 150.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
• Business Quant data shows INBX's Tax Provisions at $2000.0 in Q2 2025, $2000.0 in Q2 2024, and -$4000.0 in Q4 2023.